Evidence map›Paper›PMID 17056394›Full record

Trial reportBiological psychiatry2006

Lithium treatment effects on Myo-inositol in adolescents with bipolar depression.

Nick C Patel, Melissa P DelBello, Kim M Cecil, Caleb M Adler, Holly S Bryan, Kevin E Stanford, Stephen M Strakowski

Open access · greenAbstract readClinical TrialComparative Study
In one paragraph

Trial report in Biological psychiatry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  9. Molecular actions and clinical pharmacogenetics of lithium therapy.Pharmacology, biochemistry, and behavior · 2014
    Review
  10. A review of MR spectroscopy studies of pediatric bipolar disorder.AJNR. American journal of neuroradiology · 2014
    Review
  11. Article
  12. Article
  13. The neural effects of psychotropic medications in children and adolescents.Child and adolescent psychiatric clinics of North America · 2012
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nick C PatelDivision of Bipolar Disorders Research, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0004, USA. nick.patel@uc.edu
Melissa P DelBello
Kim M Cecil
Caleb M Adler
Holly S Bryan
Kevin E Stanford
Stephen M Strakowski
University of Cincinnati Medical Center · USCincinnati Children's Hospital Medical Center · US

Funding

Study of Prevalent Neurotoxicants in ChildrenP01ES011261 · NIEHS · CINCINNATI CHILDRENS HOSP MED CTR · PI LANPHEAR, BRUCE P · 2001 to 2006
$6.4M
Brain Abnormalities in Adolescent Bipolar DisorderK23MH063373 · NIMH · UNIVERSITY OF CINCINNATI · PI DELBELLO, MELISSA P · 2002 to 2006
$898k
Collaborative Pediatric Bipolar Disorder ConferenceU13MH064077 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BIEDERMAN, JOSEPH · 2003 to 2007
$494k
Neurobehavioral Effect of Low Level Mangenese ExposureR21ES013524 · NIEHS · UNIVERSITY OF CINCINNATI · PI HAYNES, ERIN N · 2005 to 2006
$336k
NIEHS NIH HHS ES011261NIEHS NIH HHS ES013524NIEHS NIH HHS P01 ES011261NIEHS NIH HHS R21 ES013524NIMH NIH HHS K23 MH063373NIMH NIH HHS MH63373NIMH NIH HHS U13 MH064077
6 · The paper itself

Abstract

backgroundThe neurochemical effects of lithium in adolescents with bipolar disorder largely are unknown. This study used proton magnetic resonance spectroscopy (1H MRS) to identify the in vivo effects of lithium on myo-inositol (mI) concentrations in adolescent bipolar depression.

methodsTwenty-eight adolescents (12-18 years old) with bipolar I disorder, current episode depressed, received open-label lithium 30 mg/kg, adjusted to achieve serum levels of 1.0-1.2 mEq/L. The mI concentrations in the medial as well as the left and right lateral prefrontal cortices were measured at baseline, day 7, and day 42 of treatment. Changes in mI concentrations over time were analyzed.

resultsSignificant main effects of time were observed for mI concentrations in the medial (p = .03) and right lateral (p = .05) prefrontal cortices. Baseline concentrations of mI were not significantly different from day 7 or day 42 concentrations. However, mI concentrations on day 42 were significantly higher than those on day 7 (p = .02) in both regions.

conclusionsThis study demonstrates that prefrontal mI concentrations do not significantly change from baseline after acute and chronic lithium treatment in adolescents with bipolar depression. Further investigation of the effect of lithium on mI is warranted to better understand possible mechanisms by which lithium exerts antidepressant activity.

Indexed as

AdolescentAntidepressive AgentsAspartic AcidBipolar DisorderChildFemaleHumansInositolLithium CarbonateMagnetic Resonance SpectroscopyMalePrefrontal CortexProtonsTime FactorsAntidepressive AgentsAspartic AcidInositolLithium CarbonateProtons

Identifiers

PMID17056394
PMCPMC1761698
OpenAlexW1997625146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.